Kristin Castorino
Overview
Explore the profile of Kristin Castorino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
1240
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hirsch I, Beck R, Marak M, Kudva Y, Akturk H, Bhargava A, et al.
Diabetes Care
. 2024 Dec;
48(3):353-360.
PMID: 39641970
Objective: To evaluate a regimen of inhaled Technosphere insulin (TI) plus insulin degludec in adults with type 1 diabetes, who prestudy were predominately using either an automated insulin delivery (AID)...
2.
Renard E, Weinstock R, Aleppo G, Bode B, Brown S, Castorino K, et al.
Diabetes Care
. 2024 Oct;
47(12):2248-2257.
PMID: 39423118
Objective: To examine the efficacy and safety of the tubeless Omnipod 5 automated insulin delivery (AID) system compared with pump therapy with a continuous glucose monitor (CGM) in adults with...
3.
Castorino K, Durnwald C, Ehrenberg S, Ehrhardt N, Isaacs D, Levy C, et al.
J Womens Health (Larchmt)
. 2024 Oct;
34(1):10-20.
PMID: 39378174
Gestational diabetes mellitus (GDM) is the most prevalent metabolic complication during pregnancy. GDM is associated with adverse perinatal, neonatal, and long-term health consequences. Studies have demonstrated that the use of...
4.
Hirsch I, Beck R, Marak M, Calhoun P, Mottalib A, Salhin A, et al.
Diabetes Care
. 2024 Jul;
47(9):1682-1687.
PMID: 39042575
Objective: To compare postprandial glucose excursions following a bolus with inhaled technosphere insulin (TI) or subcutaneous rapid-acting analog (RAA) insulin. Research Design And Methods: A meal challenge was completed by...
5.
Kaur R, Levy C, Castorino K, Wood-Wentz C, Rizvi S, Ozaslan B, et al.
J Endocr Soc
. 2024 May;
8(6):bvae071.
PMID: 38721109
Background: Customized and standard automated insulin delivery (AID) systems for use in pregnancies of women with preexisting type 1 diabetes (T1D) are being developed and tested to achieve pregnancy appropriate...
6.
Castorino K, Osumili B, Lakiang T, Banerjee K, Goldyn A, Piras de Oliveira C
Diabetes Ther
. 2024 Mar;
15(5):929-1045.
PMID: 38494573
Introduction: Insulin is the first-line pharmacologic therapy for women with diabetes in pregnancy. However, conducting well-designed randomized clinical trials (RCTs) and achieving recommended glycemic targets remains a challenge for this...
7.
Polsky S, Valent A, Isganaitis E, Castorino K, OMalley G, Beck S, et al.
Diabetes Technol Ther
. 2024 Feb;
26(5):307-312.
PMID: 38315503
We evaluated accuracy and safety of a seventh-generation real-time continuous glucose monitoring (CGM) system during pregnancy. Evaluable data for accuracy analysis were obtained from 96 G7 sensors (Dexcom, Inc.) worn...
8.
Pham D, Thorsell A, Castorino K, Cobb B
Endocr Connect
. 2023 Nov;
13(2).
PMID: 38010170
The main objective of this article is to provide a comprehensive review of continuous glucose monitor (CGM) use in pregnant women with type 1 diabetes (T1D) from the CONCEPTT study...
9.
Levy C, Kudva Y, Ozaslan B, Castorino K, OMalley G, Kaur R, et al.
Diabetes Care
. 2023 May;
46(7):1425-1431.
PMID: 37196353
Objective: There are no commercially available hybrid closed-loop insulin delivery systems customized to achieve pregnancy-specific glucose targets in the U.S. This study aimed to evaluate the feasibility and performance of...
10.
Alva S, Brazg R, Castorino K, Kipnes M, Liljenquist D, Liu H
Diabetes Ther
. 2023 Mar;
14(4):767-776.
PMID: 36877403
Introduction: We have evaluated the performance of the FreeStyle Libre® 3 continuous glucose monitoring system (FSL3) compared to (1) the venous plasma reference for participants aged ≥ 6 years and...